IPILIMUMAB for Small cell lung cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 474 adverse event reports in the FDA FAERS database where IPILIMUMAB was used for Small cell lung cancer.

Most Reported Side Effects for IPILIMUMAB

Side Effect	Reports	%	Deaths	Hosp.
Death	3,710	10.2%	3,709	285
Malignant neoplasm progression	3,296	9.0%	1,570	1,538
Diarrhoea	2,557	7.0%	305	1,643
Off label use	2,097	5.7%	528	731
Colitis	1,988	5.4%	293	1,229
Pyrexia	1,796	4.9%	237	1,336
Rash	1,556	4.3%	162	694
Fatigue	1,447	4.0%	176	776
Intentional product use issue	1,329	3.6%	563	347
Nausea	1,169	3.2%	139	773
Decreased appetite	990	2.7%	136	665
Immune-mediated enterocolitis	988	2.7%	73	504
Hypophysitis	981	2.7%	61	515
Dyspnoea	906	2.5%	165	651
Pneumonitis	891	2.4%	220	560